This inventor holds 1 USPTO granted patent. Top assignee: Upjohn. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Teresa Harshman: Innovator in Parenteral Formulations
Introduction
Teresa Harshman is a notable inventor based in Richland, MI (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of non-hemolytic lazaroid parenteral formulations. Her work has implications for improving patient safety during medical treatments.
Latest Patents
Teresa holds a patent for a non-hemolytic lazaroid parenteral formulation, specifically the compound 16.alpha.-Methyl-21-[4-[2,6-bis(1-pyrrolidinyl)-4-pyrimidinyl]-1-piperazinyl]pregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate. This formulation addresses the issue of hemolysis when injected. Notably, when combined with a citric acid/sodium citrate solution, both hemolysis and hypotension side effects are effectively prevented.
Career Highlights
Teresa is currently employed at Upjohn, where she continues to innovate in the pharmaceutical industry. Her expertise in formulation science has positioned her as a valuable asset to her team and the company.
Collaborations
One of her notable collaborators is Ching-Chiang Su, with whom she has worked closely on various projects related to her patent.
Conclusion
Teresa Harshman's contributions to pharmaceutical formulations demonstrate her commitment to enhancing patient care through innovative solutions. Her work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile